Abstract: The invention provides compounds of formula (I) wherein R1, R2, R3, R4, and R5 are as defined in the description, and the preparation thereof. The compounds of formula (I) are useful as pharmaceuticals.

Abstract: The present invention relates to novel benzo[g]quinoline derivatives, their preparation, their use as pharmaceuticals and pharmaceutical compositions containing them.

Abstract: The present invention relates to novel benzo [g] quinoline derivatives, their preparation, their use as pharmaceuticals for use in the treatment of glaucoma and myopia.

Abstract: The invention provides a compound of formula I wherein A, B, X, Y and R1 are as defined in the description, and a process for preparing them. The compounds of formula I are useful as pharmaceuticals.

Abstract: The present invention relates to novel benzo [g] quinoline derivatives, their preparation, their use as pharmaceuticals for use in the treatment of glaucoma and myopia.

Abstract: The invention provides a compound of formula I wherein A, B, X, Y and R1 are as defined in the description, and a process for preparing them. The compounds of formula I are useful as pharmaceutical agents for the treatment of glaucoma and myopia.

Abstract: The invention provides compounds of formula I (I) wherein R1, R2, R3, R4 and R5 are as defined in the description, and the preparation thereof. The compounds of formula I are useful as pharmaceuticals.

Abstract: The invention provides a compound of formula (I) wherein A, B, X, Y and R are as defined in the description, and a process for preparing them. The compounds of formula (I) arc useful as pharmaceuticals for the treatment of glaucoma and myopia.

Abstract: 6-hydroxy or 6-alkoxy-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoxalines bearing in position 4 an optionally substituted phenyl group may be used in the treatment of schizophrenia, drug abuse or self-injurious behavior.

Abstract: In a device for transporting sections (28) of a recording substrate from a recording mechanism, the recording mechanism has a cutting unit (12) for separating the sections (28) from the recording substrate. The cutting unit can be moved, in a cutting stroke and in a return stroke, transversely to the direction of transport (A) of the recording substrate across its width. Transport elements (32, 38) for grasping and advancing the separated sections (28) are disposed behind the cutting station in the direction of transport (A) and can be coupled by means of a gear arrangement (14, 24, 52, 50, 44, 36) to the cutting unit (12) in such a way that, upon the return stroke of the cutting unit (12), they grasp the separated section (28) and advance it in the direction of transport (A).

Abstract: The invention relates to the compound of formula I ##STR1## in free base form or in acid addition salt form its preparation and use as a medicament for glaucoma, depression, Morbus Parkinsonism or cocaine abuse.

Abstract: A drive arrangement for an ink ribbon cassette or the like having a transport roll arranged inside of the cassette permits the cassette to be inserted and ejected in a direction perpendicular to the transport roll axis relative to the receiving compartment of a ribbon device and also provides an automatic coupling between the transport roll and a drive shaft forming part of the device. The drive shaft is shiftable between a coupling position and a decoupling position set back from the coupling position against the force of spring means. On the forward end of the cassette as it is inserted perpendicular to the transport roll axis is a ramp which during the inserting movement of the cassette runs against the drive shaft and pushes it to its decoupled position. When the cassette reaches its fully inserted position the drive shaft automatically catches into the transport roll. Special actuating means are provided for decoupling the drive shaft from the transport roll.

Abstract: A compound of formula I ##STR1## wherein R.sub.1 is n-propyl,R.sub.2 is hydrogen or alkyl(C.sub.1-3),R.sub.3 is alkyl(C.sub.1-3), andR.sub.4 is hydrogen or methylin free base form or in pharmaceutically acceptable acid addition salt form is useful as a prolactin secretion inhibitor, anti-parkinson and anti-depressant agent.